Impact of President Trump's Impromptu Interview With the New York Times
President Donald Trump gave an impromptu with the New York Times Washington Correspondent Michael Schmidt at his Mar-A-Lago property Thursday. Alexander Heffner, Host of PBS' "The Open Mind," explains what this interview reveals about the relationship between Trump and the media.
"All forms of media will tank if I'm not there because without me, their ratings are going down the tubes," Trump told the NYTimes. Heffner says the report in the New York Times showcasing a thirty minute conversation with Trump amplifies the president's microphone.
"There is incest in every situation with Trump and the media," said Heffner. "There's incest when you want access." Schmidt reportedly crossed paths with Trump while he was meeting Newsmax founder Chris Ruddy at the Florida resort.
"We have to acknowledge--I think--on part of the media that its important that we use discretion, deliberation, precision in our reporting of this administration," says Heffner.
Manhattan District Attorney Alvin Bragg filed a federal lawsuit against Rep. Jim Jordan on Tuesday, accusing the Republican of a “transparent campaign to intimidate and attack” him over his prosecution of former President Donald Trump.
Nashville’s governing council voted Monday to send Justin Jones straight back to the Legislature four days after he was expelled for his role in a protest on the state House floor.
The Justice Department is calling a Texas court ruling that would halt approval of the most commonly used method of abortion in the U.S. "extraordinary and unprecedented."
Nashville city councilors will likely appoint Justin Jones to his former seat on Monday while Memphis-area county commissioners will soon announce when they'll meet to fill the vacancy left by the expulsion of Justin Pearson, which Pearson himself is eligible to fill.
Health and Human Services Secretary Xavier Becerra said "Everything is on the table" when asked if he'd recommend that the FDA ignore Friday's ruling to reverse the agency's nearly 23-year-old approval of the medication abortion drug mifepristone.
